Implanet receives CE Mark for JAZZ Standalone implant — 4 highlights

Implanet earned the CE Mark for its JAZZ Standalone implant.

Advertisement

Here are four highlights:

 

1. JAZZ Standalone leverages the JAZZ Band platform to treat adult degenerative bone disorders.

 

2. The implant features freestanding posterior fixation in place of traditional fixation systems.

 

3. The new implant is incorporated into the JAZZ product range, without need for new equipment or training.

 

4. Implanet develops vertebral and knee implants.

 

More articles on devices:
Medikon to distribute VTI’s InterFuse products in Turkey: 4 details
Medtronic’s VP for Global Affairs argues for FDA inspection changes on Capitol Hill: 5 key notes
K2M reports Q1 2017 revenue of $61.9M — 11 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.